|
Market Closed -
NYSE
04:04:06 2026-09-22 pm EDT
|
5-day change | 1st Jan Change | ||
| 103.69 USD | +0.69% |
|
+1.63% | -17.24% |
| Sep. 21 | Grail rallies as FDA staff flags no major concerns for multi-cancer test | RE |
| Sep. 18 | Trinity Heart Experts First in the Quad Cities to Use New Afib Technology | CI |
| Market Cap | 178B 156B 146B 134B 251B 17,032B 251B 1,752B 676B 8,700B 669B 654B 28,057B | P/E 2026 * |
29.4x | P/E 2027 * | 22.8x |
|---|---|---|---|---|---|
| Enterprise Value | 202B 177B 166B 151B 284B 19,320B 284B 1,987B 767B 9,869B 759B 742B 31,826B | EV / Sales 2026 * |
4.03x | EV / Sales 2027 * | 3.65x |
| Free-Float |
86.16% | Yield 2026 * |
2.48% | Yield 2027 * | 2.64% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| ABT | Delayed | |
CBOE
| ABT | Real-time | |
|
Tradegate
| ABL | Real-time | |
|
London S.E.
| ABT | Delayed | |
|
Xetra
| ABL | Delayed | |
|
CBOE
| Real-time | ||
|
Deutsche Boerse AG
| ABL | Delayed | |
|
Mexican S.E.
| ABT * | End-of-day quote | |
|
Boerse Muenchen
| ABL | Real-time | |
|
Börse Stuttgart
| ABL | Delayed | |
|
Borsa Italiana
| 1ABT | End-of-day quote | |
|
Kazakhstan S.E.
| ABT_KZ | End-of-day quote | |
|
Lima
| ABTUS | End-of-day quote | |
|
Wiener Boerse
| ABT | End-of-day quote | |
|
Swiss Exchange
| ABT | Delayed | |
|
CBOE
| ABT | Real-time | |
|
Santiago S.E.
| ABTCL | End-of-day quote | |
|
Santiago S.E.
| ABT | End-of-day quote |
Last Transcript: Abbott Laboratories
| 1 day | +0.69% | ||
| 1 week | +0.58% | ||
| Current month | -6.04% | ||
| 1 month | -11.10% | ||
| 3 months | +17.28% | ||
| 6 months | -1.68% | ||
| Current year | -17.24% |
| 1 week | 100.33 |  | 104.54 |
| 1 month | 100.33 | | 117.34 |
| Current year | 81.97 | | 129.46 |
| 1 year | 81.97 | | 136.88 |
| 3 years | 81.97 | | 141.23 |
| 5 years | 81.97 | | 142.6 |
| 10 years | 37.38 | | 142.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Ford
CEO | Chief Executive Officer | 52 | 2020-03-30 |
Philip Boudreau
DFI | Director of Finance/CFO | 53 | 2023-08-31 |
Sabina Ewing
CIO | Chief Investment Officer | 51 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Sally Blount
BRD | Director/Board Member | 64 | 2011-12-08 |
Nancy McKinstry
BRD | Director/Board Member | 67 | 2011-12-08 |
Daniel Starks
BRD | Director/Board Member | 71 | 2017-02-15 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/2/26 | Sell | Controller/Auditor | -27 | 0.0000% | ||
| 9/1/26 | Tax | Chief Financial Officer | -388 | 0.0000% | ||
| 8/25/26 | Exercice | Chief Executive Officer | 1,196,496 | 0.0691% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.69% | +0.58% | -23.78% | +4.81% | 178B | |
| -1.07% | -3.23% | -4.53% | +12.81% | 117B | |
| -0.65% | -3.62% | +8.42% | +70.03% | 60.39B | |
| +1.27% | +0.05% | -2.16% | -30.95% | 49.22B | |
| -0.22% | +0.78% | +10.27% | +47.46% | 48.02B | |
| +0.40% | +5.73% | +32.74% | +0.51% | 33.65B | |
| +7.73% | +5.65% | - | - | 28.04B | |
| +2.57% | +4.47% | +45.61% | -0.86% | 25.46B | |
| +2.38% | +12.17% | +10.97% | -11.03% | 22.5B | |
| -2.33% | -1.08% | -8.97% | +8.33% | 20.96B | |
| Average | +1.23% | +1.04% | +7.62% | +11.23% | 58.38B | |
| Weighted average by Cap. | +0.83% | -0.14% | -2.79% | +13.08% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 50.2B 43.86B 41.2B 37.62B 70.61B 4,799B 70.58B 494B 191B 2,451B 189B 184B 7,905B | 54.53B 47.64B 44.75B 40.86B 76.69B 5,212B 76.66B 536B 207B 2,662B 205B 200B 8,585B |
| Net income | 6.3B 5.51B 5.17B 4.72B 8.87B 602B 8.86B 61.96B 23.92B 308B 23.67B 23.15B 992B | 7.98B 6.97B 6.55B 5.98B 11.22B 762B 11.22B 78.42B 30.28B 390B 29.96B 29.3B 1,256B |
| Net Debt | 23.94B 20.91B 19.64B 17.94B 33.67B 2,288B 33.65B 235B 90.86B 1,169B 89.9B 87.92B 3,769B | 20.96B 18.31B 17.2B 15.71B 29.48B 2,003B 29.46B 206B 79.54B 1,023B 78.7B 76.97B 3,300B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-22 | $103.69 | +0.69% | 8,383,311 |
| 26-09-21 | $102.98 | +0.36% | 5,018,287 |
| 26-09-18 | $102.61 | +0.37% | 27,075,251 |
| 26-09-17 | $102.23 | -0.13% | 8,426,078 |
| 26-09-16 | $102.36 | +0.32% | 5,229,743 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ABT Stock
Select your edition
All financial news and data tailored to specific country editions
